StonvexLoading…
StonvexCore line items from VIVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-03 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $46.92K | $91.00K | $65.00K | $37.00K | $144.00K |
Operating Income | Not available | $-8.30M | $-5.55M | $-2.92M | $-12.62M |
Net Income | Not available | $-8.08M | $-5.39M | $-2.84M | $-2.49M |
EPS (Diluted) | $-0.19 | $-3.14 | $-2.11 | $-1.14 | $-1.70 |
Total Assets | Not available | $6.96M | $9.69M | $11.98M | $14.65M |
Total Liabilities | Not available | $2.52M | $2.62M | $2.44M | $4.16M |
Cash & Equivalents | Not available | $4.29M | $6.68M | $9.05M | $11.31M |
Free Cash Flow OCF − CapEx | Not available | $-8.59M | $-6.32M | Not available | $-9.47M |
Shares Outstanding | Not available | 2.61M | 2.61M | 2.60M | 1.90M |